Germá-Lluch J R, Alvarez I, Carrió I, Nogueras F M, Marcuello E, Estorch M, Berná L
Unidad Oncología Médica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Ann Oncol. 1991 Jun;2(6):409-15. doi: 10.1093/oxfordjournals.annonc.a057975.
We report a prospective study in two groups of colorectal cancer patients carried out by radio-immunolocalization (RIL) with F(ab') fragments of monoclonal antibodies against CEA and CA 19.9 labeled with 131-I. Twenty-two patients were studied before radical surgery and 12 patients after initial surgery, when progressive increase in CEA was registered. Scintigraphic images obtained in vivo in RIL studies were compared with scintigraphic images of the corresponding surgical specimens. Results were compared with known serum marker levels and with the presence and localization of markers in the excised specimens. RIL images correctly identified 13 of 23 (52%) primary tumors, with only one false positive image. Scintigraphy of surgical specimens correlated with RIL findings in 14 of 19 cases (74%). Four specimens which showed antibody uptake had not been visualized preoperatively in the RIL study. Two of them were retrovesical and were obscured by residual activity in the bladder. Nine of 13 (64%) patients with at least one elevated tumor marker were imaged. Staining pattern or intensity of antigen staining in the specimens did not correlate with RIL findings. Recurrent disease was confirmed by laparotomy or other exploration in 10 of the 12 patients with progressive CEA elevation during follow-up. Spontaneous normalization of CEA levels was observed in the remaining 2 patients. RIL studies were positive in 7 of the 10 patients with confirmed recurrent disease. Of the 3 false negative patients 2 had liver metastases and one developed clinical lung, bone and adrenal metastases 11 months later. No false positive studies were observed in this group.(ABSTRACT TRUNCATED AT 250 WORDS)
我们报告了一项针对两组结直肠癌患者的前瞻性研究,该研究采用了放射性免疫定位(RIL)技术,使用针对癌胚抗原(CEA)和糖类抗原19.9(CA 19.9)的单克隆抗体的F(ab')片段,并标记上131碘。对22例患者在根治性手术前进行了研究,对12例患者在初次手术后进行了研究,此时观察到CEA呈进行性升高。将RIL研究中体内获得的闪烁图像与相应手术标本的闪烁图像进行比较。结果与已知的血清标志物水平以及切除标本中标志物的存在和定位进行了比较。RIL图像正确识别出23个原发性肿瘤中的13个(52%),仅有1个假阳性图像。19例病例中有14例(74%)手术标本的闪烁扫描与RIL结果相关。4个显示有抗体摄取的标本在术前RIL研究中未显影。其中2个位于膀胱后,被膀胱内的残留活性所掩盖。13例至少有一项肿瘤标志物升高的患者中有9例(64%)被成像。标本中抗原染色的模式或强度与RIL结果无关。在随访期间CEA进行性升高的12例患者中,有10例经剖腹手术或其他探查证实有复发疾病。其余2例患者观察到CEA水平自发恢复正常。在10例经证实有复发疾病的患者中,7例RIL研究呈阳性。3例假阴性患者中,2例有肝转移,1例在11个月后出现临床肺、骨和肾上腺转移。该组未观察到假阳性研究。(摘要截短至250字)